314 related articles for article (PubMed ID: 28269784)
1. A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation.
Dong J; Qin W; Wei C; Tang Y; Wang Q; Jia J
J Alzheimers Dis; 2017; 57(2):613-623. PubMed ID: 28269784
[TBL] [Abstract][Full Text] [Related]
2. A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio.
Qiu Q; Shen L; Jia L; Wang Q; Li F; Li Y; Jia J
J Alzheimers Dis; 2019; 69(1):199-212. PubMed ID: 30958370
[TBL] [Abstract][Full Text] [Related]
3. A Novel AβPP M722K Mutation Affects Amyloid-β Secretion and Tau Phosphorylation and May Cause Early-Onset Familial Alzheimer's Disease in Chinese Individuals.
Wang Q; Jia J; Qin W; Wu L; Li D; Wang Q; Li H
J Alzheimers Dis; 2015; 47(1):157-65. PubMed ID: 26402764
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel PSEN1 Gly111Val missense mutation in a Chinese pedigree with early-onset Alzheimer's disease.
Qiu Q; Jia L; Wang Q; Zhao L; Jin H; Li T; Quan M; Xu L; Li B; Li Y; Jia J
Neurobiol Aging; 2020 Jan; 85():155.e1-155.e4. PubMed ID: 31235344
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPβ fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications.
Soto-Mercado V; Mendivil-Perez M; Velez-Pardo C; Lopera F; Jimenez-Del-Rio M
PLoS One; 2020; 15(5):e0221669. PubMed ID: 32437347
[TBL] [Abstract][Full Text] [Related]
6. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
Pimenova AA; Goate AM
Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
[TBL] [Abstract][Full Text] [Related]
7. Two novel presenilin-1 mutations (I249L and P433S) in early onset Chinese Alzheimer's pedigrees and their functional characterization.
Shen L; Qin W; Wu L; Zhou A; Tang Y; Wang Q; Jia L; Jia J
Biochem Biophys Res Commun; 2019 Aug; 516(1):264-269. PubMed ID: 31235249
[TBL] [Abstract][Full Text] [Related]
8. Gene mutations in a Han Chinese Alzheimer's disease cohort.
Ma L; Zhang J; Shi Y; Wang W; Ren Z; Xia M; Zhang Y; Yang M
Brain Behav; 2019 Jan; 9(1):e01180. PubMed ID: 30549411
[TBL] [Abstract][Full Text] [Related]
9. Chinese Presenilin-1 V97L mutation enhanced Abeta42 levels in SH-SY5Y neuroblastoma cells.
Fang B; Jia L; Jia J
Neurosci Lett; 2006 Oct; 406(1-2):33-7. PubMed ID: 16916581
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1.
Kurth V; Ogorek I; Münch C; Lopez-Rios J; Ousson S; Lehmann S; Nieweg K; Roebroek AJM; Pietrzik CU; Beher D; Weggen S
J Biol Chem; 2023 Aug; 299(8):104997. PubMed ID: 37394008
[TBL] [Abstract][Full Text] [Related]
11. Knock-in rats with homozygous
Tambini MD; D'Adamio L
J Biol Chem; 2020 May; 295(21):7442-7451. PubMed ID: 32265300
[TBL] [Abstract][Full Text] [Related]
12. A novel presenilin 1 mutation (F388L) identified in a Chinese family with early-onset Alzheimer's disease.
Zhan Y; Zheng H; Wang C; Rong Z; Xiao N; Ma Q; Zhang YW
Neurobiol Aging; 2017 Feb; 50():168.e1-168.e4. PubMed ID: 27836335
[TBL] [Abstract][Full Text] [Related]
13. A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease.
Sepulveda-Falla D; Chavez-Gutierrez L; Portelius E; Vélez JI; Dujardin S; Barrera-Ocampo A; Dinkel F; Hagel C; Puig B; Mastronardi C; Lopera F; Hyman BT; Blennow K; Arcos-Burgos M; de Strooper B; Glatzel M
Acta Neuropathol; 2021 Feb; 141(2):217-233. PubMed ID: 33319314
[TBL] [Abstract][Full Text] [Related]
14. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
15. Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.
Guo Q; Li H; Cole AL; Hur JY; Li Y; Zheng H
PLoS One; 2013; 8(11):e80706. PubMed ID: 24278307
[TBL] [Abstract][Full Text] [Related]
16. Toluidine blue O attenuates tau phosphorylation in N2a-APPSwe cells.
Onder S; Biberoglu K; Yuksel M; Tacal O
Chem Biol Interact; 2022 Oct; 366():110126. PubMed ID: 36027949
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.
Schilling S; Pradhan A; Heesch A; Helbig A; Blennow K; Koch C; Bertgen L; Koo EH; Brinkmalm G; Zetterberg H; Kins S; Eggert S
Acta Neuropathol Commun; 2023 Jun; 11(1):87. PubMed ID: 37259128
[TBL] [Abstract][Full Text] [Related]
18. The identification of PSEN1 p.Tyr159Ser mutation in a non-canonic early-onset Alzheimer's disease family.
Li H; Li Y; Liang W; Wei ZZ; Li X; Tian Y; Qiao S; Yang Y; Yang L; Wu D; Yin W; Liu H; Zhang W; Zhang Y; Wang Z
Mol Cell Neurosci; 2022 May; 120():103715. PubMed ID: 35247599
[TBL] [Abstract][Full Text] [Related]
19. Familial Alzheimer's disease mutations in presenilin 1 do not alter levels of the secreted amyloid-beta protein precursor generated by beta-secretase cleavage.
Zhang C; Browne A; Kim DY; Tanzi RE
Curr Alzheimer Res; 2010 Feb; 7(1):21-6. PubMed ID: 20205669
[TBL] [Abstract][Full Text] [Related]
20. Developing a Gene Therapy for the Treatment of Autosomal Dominant Alzheimer's Disease.
Moore B; Sharma A; Goulet M; Suter T; Pelletier C; Hu R; Schaeffer E; Kelleher RJ
Hum Gene Ther; 2023 Oct; 34(19-20):1049-1063. PubMed ID: 37578141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
